Home › Breast Cancer › NCT07179809
Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer
Recruiting
Pilot Randomized Trial of a Virtual, Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer: Exploring Dose of Support to Optimize Adherence
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: 1. Patients with HR+/HER2 negative MBC 2. On first- or second-line treatment 3. Life expectancy at least 12 months 4. Only females 5. Age 18 years or older 6. Able to read, write, and speak English 7. Willingness to follow protocol requirements 8. Have a smartphone with access to cellular service or computer access with internet service 9. Oriented to person, place, and time 10. Consume less than 3 servings of fruit and vegetable/day 11. Engage in less than 150 minutes moderate/vigorous intensity activity per week, defined as anything that causes small increases in breathing or heart rate for a sustained amount of time (e.g., brisk walking, bicycling) 12. Engage in a mind-body practice less than 4 times a month Exclusion Criteria: 1. Another primary cancer diagnosis within past 5 years (not including non-melanoma skin cancers) 2. Any major thought disorder (e.g., schizophrenia, dementia) 3. Communication barriers (e.g., hard of hearing) 4. Poorly-controlled or uncontrolled diabetes in the opinion of the physician(s) 5. Extreme mobility issues (e.g., unable to get in and out of a chair unassisted)
About the study
The research study is to learn how the ACLP can best support patients with stable HR+/HER2- MBC.
What is being tested
- Demographics/Lifestyle Survey (other)
Sponsor: M.D. Anderson Cancer Center · Participants: 100 · Started: Aug 21, 2026
Contact the study team
- Meroe Morse, MD · Phone: 713-794-4053
Official record on ClinicalTrials.gov — NCT07179809
Locations in the U.S.
| Texas | The University of Texas M. D. Anderson Cancer Center, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.